An evaluation of pharmacists' general attitudes, knowledge, and phobias regarding medications that include corticosteroids: a cross-sectional study.
Journal
Journal of pharmaceutical health care and sciences
ISSN: 2055-0294
Titre abrégé: J Pharm Health Care Sci
Pays: England
ID NLM: 101672177
Informations de publication
Date de publication:
01 Feb 2024
01 Feb 2024
Historique:
received:
12
08
2023
accepted:
18
01
2024
medline:
2
2
2024
pubmed:
2
2
2024
entrez:
2
2
2024
Statut:
epublish
Résumé
Corticosteroid-containing medications are widely accessible in various forms, including topical, injectable, and inhaled formulations. Due to uncertain safety profiles, healthcare providers, including pharmacists, often express apprehension when dispensing these drugs. This cross-sectional study assesses the knowledge, attitudes, and phobia of Jordanian pharmacists regarding corticosteroid-containing medications. Conducted through a self-administered online questionnaire. the study reveals that dermatological conditions and respiratory disorders are the primary indications for prescribing corticosteroid-containing drugs. The most reported side effects among pharmacists' patients include increased appetite, diabetes, and skin thinning. Pharmacists generally exhibit acceptable knowledge, with a median score of 9.0 out of 11.0 (IQR = 3.0). Over two-thirds of pharmacists (69.9%) achieve a high knowledge score (Bloom's cut-off point ≥ 8.8). However, only 55.7% are aware that corticosteroids may induce mood changes. High phobia scores, particularly concerning increased blood pressure and osteoporosis risks, indicate pharmacist reservations in corticosteroid dispensing. Interestingly, pharmacists in rural areas display lower knowledge scores, while those working outside community pharmacies exhibit lower phobia scores compared to their counterparts in urban areas and community pharmacies, respectively. Despite generally good knowledge levels, the study underscores high phobia scores among Jordanian pharmacists regarding corticosteroid dispensing, particularly due to concerns about blood pressure elevation and osteoporosis risks. This suggests a potential need for targeted educational interventions and support systems to enhance pharmacist confidence and optimize corticosteroid usage while minimizing associated risks.
Sections du résumé
BACKGROUND
BACKGROUND
Corticosteroid-containing medications are widely accessible in various forms, including topical, injectable, and inhaled formulations. Due to uncertain safety profiles, healthcare providers, including pharmacists, often express apprehension when dispensing these drugs. This cross-sectional study assesses the knowledge, attitudes, and phobia of Jordanian pharmacists regarding corticosteroid-containing medications.
METHODS
METHODS
Conducted through a self-administered online questionnaire.
RESULTS
RESULTS
the study reveals that dermatological conditions and respiratory disorders are the primary indications for prescribing corticosteroid-containing drugs. The most reported side effects among pharmacists' patients include increased appetite, diabetes, and skin thinning. Pharmacists generally exhibit acceptable knowledge, with a median score of 9.0 out of 11.0 (IQR = 3.0). Over two-thirds of pharmacists (69.9%) achieve a high knowledge score (Bloom's cut-off point ≥ 8.8). However, only 55.7% are aware that corticosteroids may induce mood changes. High phobia scores, particularly concerning increased blood pressure and osteoporosis risks, indicate pharmacist reservations in corticosteroid dispensing. Interestingly, pharmacists in rural areas display lower knowledge scores, while those working outside community pharmacies exhibit lower phobia scores compared to their counterparts in urban areas and community pharmacies, respectively.
CONCLUSION
CONCLUSIONS
Despite generally good knowledge levels, the study underscores high phobia scores among Jordanian pharmacists regarding corticosteroid dispensing, particularly due to concerns about blood pressure elevation and osteoporosis risks. This suggests a potential need for targeted educational interventions and support systems to enhance pharmacist confidence and optimize corticosteroid usage while minimizing associated risks.
Identifiants
pubmed: 38303076
doi: 10.1186/s40780-024-00329-x
pii: 10.1186/s40780-024-00329-x
doi:
Types de publication
Journal Article
Langues
eng
Pagination
8Informations de copyright
© 2024. The Author(s).
Références
Michelle Kapugi KC, Corticosteroids Pharmacology CE. 2019;38(5):4.
Nazir A, Masih M, Iqbal M. Formulation, optimization, qualitative and quantitative analysis of new dosage form of corticosteroid. Future J Pharm Sci. 2021;7:11.
Bos B, et al. Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers. Pediatr Dermatol. 2019;36(1):100–4.
doi: 10.1111/pde.13698
pubmed: 30338542
Mueller SM et al. Assessment of corticophobia as an indicator of non-adherence to topical corticosteroids: a pilot study. J Dermatological Treat, 2016: p. 9.
Duyvendak M, et al. Doctors’ beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention. J Clin Pharm Ther. 2011;36:11.
doi: 10.1111/j.1365-2710.2010.01185.x
Kang MJ. Community pharmacists’ knowledge, perceptions, and practices about topical corticosteroid counseling: a real-world cross-sectional survey and focus group discussions in Korea. PLoS ONE. 2020;15(7):15.
doi: 10.1371/journal.pone.0236797
Jaffuel D et al. Perception of oral corticosteroids in adult patients with asthma in France. J Asthma. 2020;13.
Oluwaseyi I. The Perceived Accompanying Dangers Of Dexamethasone (A Corticosteroid) Use In Covid-19 Management. 2020 6/2020; Available from: https://www.researchgate.net/publication/342282696_THE_PERCEIVED_ACCOMPANYING_DANGERS_OF_DEXAMETHASONE_A_CORTICOSTEROID_USE_IN_COVID-19_MANAGEMENT .
Annane D. Corticosteroids for COVID-19. J Intensive Med. 2021;1(01):14–25.
doi: 10.1016/j.jointm.2021.01.002
pmcid: 7919540
pubmed: 36943816
Annane D, Bollaert BE, Briegel PE, Keh J, Kupfer D, Pirracchio Y, Rochwerg R. B, Corticosteroids for treating sepsis in children and adults 2019: p. 163.
Russell B et al. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? Ecancermedicalscience. 2020;14.
Barakat M, et al. Assessment of Knowledge, Perception, Experience and Phobia toward corticosteroids Use among the General Public in the era of COVID-19: a multinational study. Healthcare. 2023;11(2):255.
doi: 10.3390/healthcare11020255
pmcid: 9859254
pubmed: 36673623
Dahdal S. Using the WhatsApp social media application for active learning. J Educational Technol Syst. 2020;49(2):239–49.
doi: 10.1177/0047239520928307
Mayfield A. What is social media 2008.
Habes M, et al. The relationship between social media and academic performance: Facebook perspective. Int J Inf Technol Lang Stud. 2018;2(1):12–8.
Utz S. Is LinkedIn making you more successful? The informational benefits derived from public social media. New Media Society. 2016;18(11):2685–702.
doi: 10.1177/1461444815604143
Ahmad DS, Wazaify MM. Albsoul-Younes, the role of the clinical pharmacist in the identification and management of corticophobia–an interventional study. Trop J Pharm Res. 2014;13(3):445–53.
Choi E, Chandran NS, Tan C. Corticosteroid phobia: a questionnaire study using TOPICOP score. Singapore Med J. 2020;61(3):149.
doi: 10.11622/smedj.2019110
pmcid: 7905116
pubmed: 32488277
El Hachem M, et al. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey. Ital J Pediatr. 2017;43(1):22.
doi: 10.1186/s13052-017-0330-7
pmcid: 5330138
pubmed: 28245844
Boynton PM. Administering, analysing, and reporting your questionnaire. BMJ. 2004;328(7452):1372–5.
doi: 10.1136/bmj.328.7452.1372
pmcid: 420299
pubmed: 15178620
Kaliyaperumal K. Guideline for conducting a knowledge, attitude and practice (KAP) study. AECS Illumination. 2004;4(1):7–9.
Abazid H et al. Public knowledge, beliefs, psychological responses, and behavioural changes during the outbreak of COVID-19 in the Middle East. Pharm Pract. 2021;19(2).
Service. NH. Topical corticosteroids. 2020 [cited 2023 11/5]; Available from: https://www.nhs.uk/conditions/topical-steroids/ .
American Academy of Allergy, A.I. Over-The-Counter Allergy Nasal Steroid Sprays - What Does It Mean For Patients? 2020 [cited 2023 11/5]; Available from: https://www.aaaai.org/tools-for-the-public/conditions-library/allergies/triamcinolone-nasal-spray .
Barnes PJ. Inhaled corticosteroids. Pharmaceuticals. 2010;3(3):514–40.
doi: 10.3390/ph3030514
pmcid: 4033967
pubmed: 27713266
Lohia S, Schlosser R, Soler Z. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68(5):569–79.
doi: 10.1111/all.12124
pubmed: 23590215
Hodgens A, Sharman T. Corticosteroids, in StatPearls [Internet]. 2022, StatPearls Publishing.
Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33(4):289–94.
doi: 10.1097/00004836-200110000-00006
pubmed: 11588541
Peppa M, Krania M, Raptis SA. Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids: a review. Integr Blood Press Control. 2011;7–16.
Willox JC, et al. Prednisolone as an appetite stimulant in patients with cancer. Br Med J (Clinical Res ed). 1984;288(6410):27.
doi: 10.1136/bmj.288.6410.27
Keijsers CJ, et al. A comparison of medical and pharmacy students’ knowledge and skills of pharmacology and pharmacotherapy. Br J Clin Pharmacol. 2014;78(4):781–8.
doi: 10.1111/bcp.12396
pmcid: 4239972
pubmed: 24698099
Keijsers CJ, et al. Pharmacists’ and general practitioners’ pharmacology knowledge and pharmacotherapy skills. J Clin Pharmacol. 2015;55(8):936–43.
doi: 10.1002/jcph.500
pubmed: 25810359
Elayeh E, et al. Practice of pharmaceutical care in community pharmacies in Jordan. Trop J Pharm Res. 2017;16(2):463–70.
doi: 10.4314/tjpr.v16i2.27
Rayan A, Jaradat A. Stigma of mental illness and attitudes toward psychological help-seeking in Jordanian university students. Res Psychol Behav Sci. 2016;4(1):7–14.
Al Ali NM, et al. Factors affecting help-seeking attitudes regarding mental health services among attendance of primary health care centers in Jordan. Int J Mental Health. 2017;46(1):38–51.
doi: 10.1080/00207411.2016.1264039
Hasan AA-H, Musleh M. Public stigma toward mental illness in Jordan: a cross-sectional survey of family members of individuals with schizophrenia, depression, and anxiety. J PsychoSoc Nurs Ment Health Serv. 2017;55(6):36–43.
doi: 10.3928/02793695-20170519-05
pubmed: 28585666
Barakat M, et al. Evaluation of knowledge, experiences, and fear toward prescribing and dispensing corticosteroids among Egyptian healthcare professionals: a cross-sectional study. Saudi Pharm J. 2023;31(10):101777.
doi: 10.1016/j.jsps.2023.101777
pmcid: 10523270
pubmed: 37771957
Engels F. Pharmacology education: reflections and challenges. Eur J Pharmacol. 2018;833:392–5.
doi: 10.1016/j.ejphar.2018.06.032
pubmed: 29935169
Pathak GN, et al. The Pharmacist’s role in dermatology: patient medication adherence. J Dermatol. 2023;50(9):1099–107.
doi: 10.1111/1346-8138.16895
pubmed: 37489577
Info. AU. Universities in Jordan. 2023 [cited 2023 11/5]; Available from: https://www.alluniversity.info/jordan/ .
Basheti IA et al. Primary health care policy and vision for community pharmacy and pharmacists in Jordan. Pharm Pract (Granada). 2020;18(4).
Reddy A, et al. Interruptions in community pharmacies: frequency, sources, and mitigation strategies. Res Social Administrative Pharm. 2019;15(10):1243–50.
doi: 10.1016/j.sapharm.2018.10.030